⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
ABSLAMC - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.6
| Stock Code | ABSLAMC | Market Cap | 27,966 Cr. | Current Price | 968 ₹ | High / Low | 1,047 ₹ |
| Stock P/E | 27.3 | Book Value | 123 ₹ | Dividend Yield | 2.48 % | ROCE | 35.5 % |
| ROE | 27.0 % | Face Value | 5.00 ₹ | DMA 50 | 876 ₹ | DMA 200 | 809 ₹ |
| Chg in FII Hold | -0.13 % | Chg in DII Hold | 0.49 % | PAT Qtr | 274 Cr. | PAT Prev Qtr | 245 Cr. |
| RSI | 59.8 | MACD | 31.6 | Volume | 5,58,702 | Avg Vol 1Wk | 8,41,116 |
| Low price | 556 ₹ | High price | 1,047 ₹ | PEG Ratio | 2.30 | Debt to equity | 0.02 |
| 52w Index | 84.0 % | Qtr Profit Var | 23.4 % | EPS | 35.4 ₹ | Industry PE | 27.5 |
📊 Core Financials
- Profitability: PAT improved from ₹245 Cr. to ₹274 Cr. (Qtr Profit Var: +23.4%)
- Margins: ROE at 27.0% and ROCE at 35.5% indicate strong efficiency
- Debt: Debt-to-equity ratio at 0.02 shows negligible leverage
- Cash Flow: EPS at ₹35.4 reflects solid earnings
💰 Valuation Indicators
- P/E Ratio: 27.3 vs Industry PE of 27.5 → fairly valued
- P/B Ratio: Current Price ₹968 vs Book Value ₹123 → ~7.9x book
- PEG Ratio: 2.30 → growth priced at a premium
- Intrinsic Value: Valuation supported by strong fundamentals but slightly expensive
🏢 Business Model & Health
- Market Cap: ₹27,966 Cr. reflects strong presence in asset management
- Dividend Yield: 2.48% provides healthy shareholder return
- Competitive Advantage: Established brand in mutual funds and asset management
- Overall Health: Strong profitability, low debt, and fair valuation
🎯 Entry Zone & Long-Term Guidance
- Entry Zone: Attractive near ₹900–940 for accumulation
- Long-Term Holding: Suitable for long-term investors given strong fundamentals and dividend yield
✅ Positive
- Strong ROE (27.0%) and ROCE (35.5%)
- Negligible debt-to-equity ratio (0.02)
- Healthy dividend yield (2.48%)
⚠️ Limitation
- P/B ratio ~7.9x indicates premium valuation
- PEG ratio (2.30) suggests growth priced at a premium
- FII holding decreased (-0.13%)
📉 Company Negative News
- FII holding decreased (-0.13%)
- Stock trading slightly above DMA levels (50DMA ₹876, 200DMA ₹809), indicating limited upside
📈 Company Positive News
- Quarterly PAT rose to ₹274 Cr. (+23.4%)
- DII holding increased (+0.49%)
🏭 Industry
- Industry PE: 27.5, in line with ABSLAMC’s PE
- Asset management sector benefits from rising retail participation in mutual funds
🔎 Conclusion
ABSLAMC demonstrates strong profitability, efficiency, and negligible debt, making it a fundamentally sound company.
Valuations are fair but slightly premium compared to book value.
With a healthy dividend yield and rising domestic institutional interest, the stock is suitable for long-term holding, with entry recommended near ₹900–940 to optimize risk-reward balance.